Stop taking steroids: Kidney transplant recipients may not need long-term prednisone

January 26, 2012

Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Also, doing so does not appear to jeopardize the long-term survival of transplant patients and their new organs.

Historically, most have taken large doses of the immunosuppressive steroid prednisone to help keep their bodies from rejecting their new organ. Unfortunately, though, prolonged use of high-dose prednisone can cause serious side effects including high blood pressure, high cholesterol, diabetes, cataracts, bone loss, increased , mood swings, and, in children, growth retardation.

Because of these side effects, numerous recent clinical studies have tested whether it's safe to use other and to minimize or eliminate prednisone after a kidney transplant.

Because the majority of these clinical trials followed patients for less than five years, Arthur Matas, MD (University of Minnesota, Minneapolis) and his colleagues conducted a long term, 10-year study that followed 1,241 on a that included rapid discontinuation of prednisone (within five days of transplantation). The study included 791 patients who received kidneys from live donors and 450 who received kidneys from deceased donors.

Among the major findings after 10 years:

  • 71% of patients who received kidneys from living donors and 62% of those who received kidneys from deceased donors survived.
  • 61% of kidneys from living donors and 51% of kidneys from deceased donors survived.
  • Early organ rejection rates were 25% and 31% for deceased and living donor kidneys respectively.
  • Chronic organ rejection rates were 39% and 47% for deceased and living respectively.
  • The incidence rates of new-onset diabetes and several other complications were significantly lower than rates typically seen in transplant patients on prednisone.
These findings indicate that the long-term patient and kidney survival rates are similar for transplant recipients who quickly stop taking prednisone and recipients who continue to take it (based on national averages). Importantly, rapid prednisone discontinuation significantly reduced the rate of steroid-related side effects. However, this was not a randomized trial so additional studies are needed.

"Because prednisone use is associated with numerous side effects, transplant recipients say it is the drug they would most like to avoid. Our data suggest that long-term prednisone may not be necessary after a kidney transplant," said Dr. Matas. "About 30% of new kidney transplants in the United States are now done with a protocol similar to ours," he added.

Explore further: Never too old to donate a kidney?

More information: The article, entitled "Ten-Year Outcome after Rapid Discontinuation of Prednisone in Adult Primary Kidney Transplantation," will appear online on January 26, 2012, doi: 10.2215/CJN.08630811

Related Stories

Never too old to donate a kidney?

October 28, 2011
People over age 70 years of age can safely donate a kidney, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results provide good news for patients ...

Best post-transplant drug regimen identified for patients with new kidneys

July 29, 2011
For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive ...

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.